1.Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers
Xiaodan JIANG ; Yan JIANG ; Senbiao LUO ; Karthik SEKAR ; Clara Kai Ting KOH ; Amudha DEIVASIGAMANI ; Qingzhe DONG ; Niankai ZHANG ; Shenling LI ; Fengyun HAO ; Brian Kim Poh GOH ; London Lucien OOI ; Yu WANG ; Kam Man HUI
Cancer Research and Treatment 2021;53(4):944-961
Purpose:
NUF2 has been implicated in multiple cancers recently, suggesting NUF2 may play a role in the common tumorigenesis process. In this study, we aim to perform comprehensive meta-analysis of NUF2 expression in the cancer types included in the Cancer Genome Atlas (TCGA).
Materials and Methods:
RNA-sequencing data in 31 cancer types in the TCGA data and 11 independent datasets were used to examine NUF2 expression. Silencing NUF2 using targeting shRNAs in hepatocellular carcinoma (HCC) cell lines was used to evaluate NUF2’s role in HCC in vitro and in vivo.
Results:
NUF2 up-regulation is significantly observed in 23 out of the 31 cancer types in the TCGA datasets and validated in 13 major cancer types using 11 independent datasets. NUF2 overexpression was clinically important as high NUF2 was significantly associated with tumor stages in eight different cancers. High NUF2 was also associated with significantly poorer patient overall survival and disease-free survival in eight and six cancers, respectively. We proceeded to validate NUF2 overexpression and its negative association with overall survival at the protein level in an independent cohort of 40 HCC patients. Compared to the non-targeting controls, NUF2 knockdown cells showed significantly reduced ability to grow, migrate into a scratch wound and invade the 8 μm porous membrane in vitro. Moreover, NUF2 knockdown cells also formed significantly smaller tumors than control cells in mouse xenograft assays in vivo.
Conclusion
NUF2 up-regulation is a common feature of many cancers. The prognostic potential and functional impact of NUF2 up-regulation warrant further studies.
2.Multicenter Evaluation of the Molecular Line Probe Assay for Multidrug Resistant Mycobacterium Tuberculosis Detection in China.
Qiang LI ; Hai Yan DONG ; Yu PANG ; Hui XIA ; Xi Chao OU ; Zhi Ying ZHANG ; Jun Chen LI ; Jian Kang ZHANG ; Shi Tong HUAN ; Daniel P CHIN ; Kai Man KAM ; Yan Lin ZHAO
Biomedical and Environmental Sciences 2015;28(6):464-467
In order to evaluate the performance of a molecular Hain line probe assay (Hain LPA) for rapid detection of rifampicin and isoniazid resistance of Mycobacterium tuberculosis in China, 1612 smear positive patients were consecutively enrolled in this study. Smear positive sputum specimens were collected for Hain LPA and conventional drug susceptibility testing (DST). The sensitivity and specificity of Hain LPA were analyzed by using conventional DST as golden reference. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for rifampicin resistance detection were 88.33%, 97.66%, 81.54%, and 98.62%, respectively. The sensitivity, specificity, PPV and NPV for isoniazid resistance detection were 80.25%, 98.07%, 87.25%, and 96.78%, respectively. These findings suggested that Hain LPA can be an effective method worthy of broader use in China.
China
;
Genotyping Techniques
;
methods
;
Humans
;
Isoniazid
;
pharmacology
;
Mycobacterium tuberculosis
;
drug effects
;
genetics
;
isolation & purification
;
Rifampin
;
pharmacology
;
Tuberculosis, Multidrug-Resistant
;
diagnosis
;
microbiology